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ABSTRACT: Some secondary metabolites of herbs and certain products of traditional systems 
of medicine as possible sources of anti-AIDS drug potentials are presented and discussed. 
 
INTRODUCTION 
 
WHO, the apex body of the health care of 
the population has recently recognized that, 
traditional system of medicine can 
contribute significantly to certain conditions 
for which no definite solutions are available 
in the allopathic system.  AIDS is one such 
immunosuppressive dreadful disease.     
Several compounds with different chemical 
structures have been reported as having 
significant inhibitory effect against HIV in 
vitro.  Series of 2’, 3’ – dideoxy nucleoside 
compounds have also been synthesized and 
evaluated for such activity
1.  In the present 
paper,  in order to develop natural products 
as chemotherapeutic agents, bio-active 
chemicals, plants and plant products which 
are reported to have anti-HIV activity or 
expected to possess such activity are 
reviewed and discussed. 
 
The essential aspects to remember in the 
development of plant products in the 
management of AIDS are  
 
(i)  Selection of proper plants. 
(ii)  Selection of proper extraction and 
isolation procedure, 
(iii)  Selection of proper model for testing 
 
(i)  Selection of plants 
 
Though the selection of the right species 
from a vast source for a particular ailment is 
difficult, one can adopt the following 
methods. 
 
a)  A systematic examination for the anti-
HIV principle can be initiated only, if an 
adequate background regarding the 
effectiveness of certain plants is 
available. 
 
b)  In the event that such a therapeutic agent 
is available only in small quantities, it is 
desirable to go in for chemo-
taxonomically related plants, because 
most often botanically related plants 
produce identical or closely related 
chemicals. 
 
c)  The third method available is random 
selection i.e either from actual 
experience or from literature survey, if a 
particular plant is found to give 
encouraging results, it is desirable to 
increase the number of plants hopefully 
for investigation, by taking more plants 
belonging to the same general and 
families. 
 
(ii)  Selection for extraction and 
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Conventional methods are good enough for 
molecules that  are present in larger 
quantities.  Newer methods, developed for 
the more complex molecules have also to be 
adopted.  In order to double check the 
efficacy of extraction and isolation, a 
concurrent biological screening with the 
extractives is also to be called for.  After 
evaluating the potency of the extracts, the 
isolation of the active principles should be 
taken up. 
 
DRUG THERAPY 
 
There are two aspects in tackling the disease 
(a) the curative aspect (b) the preventive 
aspect.  The traditional system of medicine 
lays great stress on developing immunity or 
resistance of the body through food, diet and 
drugs.  For the curative aspect, from rain 
water to seaweed, the medicinal qualities 
that nature has are amazing.  According to 
one account more than 3000 species of 
plants find extensive use in day-to-day 
practice
2.  The bio-active chemicals that are 
found in the plants in general  are the 
secondary metabolites which make them 
important as potent drugs.  Alkaloids, 
steroids, triterpenoids, flavonoids, phenols, 
tannins, saponins are some of the secondary 
metabolites. 
 
With this background, let us now take stock 
of the bio-active secondary metabolites 
which are at present reported to possess anti 
– HIV activity and the plants/plant products 
or related family which can generate similar 
chemotype principles for development of 
newer anti-HIV drugs. 
 
Echinacea species (Compositae) have been 
used for many diseases and conditions as 
antiviral, antibiotic, antibacterial, anti-
inflammatory, immunostimulat and 
vulnerary.  Its immunostimulant property 
could make it potentially useful in 
conditions such as allergies, cancers, chronic 
infections and AIDS
3. 
 
New plant tannins were evaluated as 
potential inhibitors of HIV replication
4.  The 
tetragalloyl quinic acids, viz. 3, 5-di-O-
galloyl-4-O-digalloylquinic acid, 3,4-di-O-
galloyl, 5-O-digalloyl quinic acid, 3-O-
digalloyl-4, 5-di-O-galloyl quinic acid were 
found to inhibit Reverse Transcript activity  
90,89 and 84% at 100 µM  and 73,70 and 
63% at 30 µM respectvely
5. 
 
Castanospermine obtained from 
Castanospermum australs A. Cunn. (Legu 
minosae) has been approved by the Food 
and Drug Administration of USA as an anti-
AIDS Drug.  It is also present in the genus 
Alexa
6,7 of the same family. 
 
Calanolides (coumarin derivatives) from 
Calophyllum lanigerum  (G attiferae) are 
reported to be a new anti-HIV phenotype for 
drug development
8.  The alkaloids, 
muchellamin A and B of Ancistroclaclus 
abbreviatus  (Ancistrocladaceae) inhibited 
the production of viral – RT in HIV infected 
CEM-SS cells
9.  Salasoermic acid (titrapene) 
as inhibitor of HIV-RT and HIV-RT and 
HIV replication I Hglymphocyte cells was 
reported from the roots of Tripterygeium 
wilfodii  Hook.f. (Celastraceae
10).  
Tripterifordin, a new kaurane type diterpene 
lactone from T.wilfodii  also showed anti-
HIV replication activity with an EC 50 of 1 
µg/ml
11. 
 
The three falvonoid alkaloids viz O-
dimethyl buchenavianine N, O-didemethyl 
tuchenavianine and the buchenavianine from 
the leaves of Buchenavia capitata (Vahl) 
Eichl  (Combretaceae) represent a new 
chemotype for anti-HIV activity
12.  Out of 
new 100 plant extracts screened for anti-
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Nattuvadumai – Terminalia catappa L. and 
T.alata  (Combretaceae) are found to have 
97% and 90% inhibitory activity 
respectively
13.  T. alata root bark was found 
to contain cleanolic acid, arjunic acid, 
arjunetin, arjunolic and ellagic acid
14.  
Marudu – T.arjuna W & A resulted in the 
isolation of gallic acid, ellagic acid, 
arjunolic acid, arjunglucoside.  The different 
constituents identified in the fruits of 
tanrikkai/vibhitaki – T.beleric Roxb. include 
β-sitosterol, gallic acid, ellagic acid, ethyl 
gallate, galloyl glucose, Chebulagic acid and 
bellericanin
15,16.  Presence of these 
polyhydroxy compounds particularly gallic 
and ellagic acid in T.arjuna  W.A  and 
T.belerica Roxb.  Similar to T.alata of the 
same family is definitely suggestive of these 
two plants possessing anti-HIV potentiality. 
 
Saponin B1 from soyabean Glycine max 
merr (Leguminosae) is reported to have 
inhibitory activity against HIV infection
17.  
The drug serankottai / bhallataka –
semecarpus anacadium  Lenn.f. 
(Anacardiaceae) is claimed to possess anti-
AIDS activity.  It contains  several 
biflavonoids which has phenolic 
hydroxyls
18.  Nilavembu / Kirata tikta – 
Swertia chirata Buch. Ham (Gentianaceae) 
is used as blood purifier, appetizer, and in 
intermittent fever including malaria.   
Chemical examination has yielded several 
xanthaones (poly hydroxyl compounds)
19.  
The presence of many poly phenolic 
compounds in larger amounts supports the 
suggestion to these plants being possible 
anti-HIV drugs. 
 
Psoralen from Karpokarici / Bakuchi – 
Psoralea coryfolia  L. (Leguminosae) was 
investigated for AIDS therapy
20.  The seeds 
of bakuchi contain an essential oil (0.05%), 
resin (8.6%),  bukuchiol, flavones and 
several coumarin compounds which might 
possess anti- AIDS property.  The following 
plant
21  are also suggested for screening 
based on the close structural relationship of 
the phytochemicals present in them with the 
reported anti-AIDS drugs. 
 
 
Valuluvai    - Celastrus paniculatus  Willd  
(Jyotishmati)      (Celastraceae) 
Nannari    - Hemidesmis indicus R. Br. 
(Sariva)       (Asclepiadaceae) 
Thottalvadi    - Mimosa pudica L. (Leguminosae) 
        (Lajjalu) 
Kungiliyam    - Shorea robusta Gaertn 
(Salaniryasa)       (Diperocarpaceae) 
Vellarikkai    - Cucumis sativus L. (Cucurbiataceae) 
Saraipparuppu   - Buchnania lansen Speng 
(piyalaka)      (Anacardiaceae) 
Ma (arma)    - Mangifera indica L. (Anacardiaceae) 
Carrot     - Daucus carota (umblliferae) Pages 91- 98 
 
Ilanthai (Badari)  - Zizyphus jujube (Rhamnaceae) 
Vembu (Nimba)  - Azadirachta indica L. (Meliaceae) 
 
Marine products: 
Not only plant products, the bio-active 
chemicals from marine animals are also 
reported to possess anti-HIV  activity.  
Sphingosine, sphinganine, their amides with 
fatty acids of 16 to 26 carbon atoms 
(ceramides) and closely related compounds 
are important components in both plant and 
animal cells.  Some of the ceramides are 
found to be effective against AIDS and HIV 
related diseases and also for the treatment of 
multiple sclerosis.  A soft coral – Nephthea 
sp. and a seaworm have afforded (+) – 
erythro  –  2  –  amino  –  4E, 8Z, 
octadecadiene, 1,3-diol N-palmitate; clams-
Solen bravis  and  Barnea candida  gave  2-
amino-4E-octadecaene-1, 3-diol  palmitate.  
Holothuroid  –  Thorsonia investigatoris 
resulted in the isolation of a pair of 
ceramide-1-glucoside
22.  These ceramides 
expected to have anti-AIDS activity need 
screening. 
 
Compound formulations 
 
Apparantly these are the plant suggested for 
further study to develop a new 
chemotherapeutic agent for AIDS.  In 
traditional medical practice, generally the 
plants are often used in the compound form 
to which other herbs, metals, minerals and 
animal products are added.  Thus the 
following siddha compound formulations 
herbal and herbomineral which are expected 
to possess anti-HIV potentials are also 
suggested as they are described in literature 
for sexually transmitted diseases
23. 
 
1.  Maha vallathi ilekiyam 
2.  Ven pucani ney 
3.  Kungiliya parpam 
4.  Panca thipakkini curanam 
5.  Venpucani ilekiyam 
6.  Cenkottai ney 
 
Anti-AIDS potentials from metals and 
mineral drugs which have not been 
examined so far, also need screening. 
 
1.  Poornachandiroyam 
2.  Iraca kanthi mezhuku 
3.  Parangi pattai pathangam 
4.  Kanthaga iracayanam 
5.  Iraca centuram 
6.  Iedivallathi mezhuku 
7.  Iraca mezhuku 
8.  Nanthimezhuku 
 
Because of the toxicological findings, 
medicines of metals and minerals are not 
being paid much attention to, by the modern 
medical physician and increasingly so by 
many a traditional medical practitioners.   
However, the  persisting use of these 
materials in certain diseases and diseases 
arising out of the deficiency of some of 
these elements is note worthy. 
 
Chromium, cobalt, copper, fluorine, iodine, 
iron, manganese, molybdenum, nickel, 
selenium, silicon, tin and vanadium are 
essential trace elements besides the major 
ones like sodium, potassium, phosphorus 
etc.  The most dreaded ‘mercury’ has 
apparently not yet been adequately studied 
for use in AIDS
24.  It is sure that these Pages 91- 98 
 
elements in their inorganic or compound 
forms might also possess anti-AIDS 
potentials. 
 
Preventive aspect 
 
Prevention of diseases and prevention as 
well as promotion of positive health are 
emphasized in traditional medical practices.  
These measures are called rasayana or 
rejuvenation of body and mind.  The 
following remedies can be used for 
promoting the power of body resistance. 
 
Vallari   - Centella asiatica L. 
(Saraswatha)     (Urban) (Umbelliferae) 
 
Nellikai  - Emblica officinale 
(Amalaki)    Gaertn (Euphorbiaceae) 
 
Amukkara  - Withania somnifera 
       Dunal (Solanaceae) 
 
Satavari  - Asparagus racemosus 
      Willd (Liliaceae ) 
 
Katukkai  - Terminalia chebula 
(Haritaki)     (Combretaceae) 
 
The kayakalpa drugs described in Siddha 
system of medicine and the following 
compound preparation are also administered 
to promote the power of body resistance and 
revitalizing the immune
25,26. 
 
1.  Cyavan prasa 
2.  Dhatri rasayana 
3.  Brahmi ghrta 
4.  Asvagandhadi lehya 
5.  Satavari paka 
6.  Agastya rasayana 
 
CONCLUSION 
 
Plants/plant products and compound 
preparations discussed so far could be taken 
up for further studies for tackling the AIDS 
problem. 
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